JAG
Jaguar Health
Stock
Stock
ISIN: US47010C8055
Ticker: JAGX
US47010C8055
JAGX
Price
Price
CHART BY
Frequently asked questions
What is Jaguar Health's market capitalization?
The market capitalization of Jaguar Health is $13.96M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Jaguar Health?
Jaguar Health's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$16.10. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Jaguar Health's stock?
Currently, 1 analysts cover Jaguar Health's stock, with a consensus target price of $6.00. Analyst ratings provide insights into the stock's expected performance.
What is Jaguar Health's revenue over the trailing twelve months?
Over the trailing twelve months, Jaguar Health reported a revenue of $10.48M.
What is the EBITDA for Jaguar Health?
Jaguar Health's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$27.50M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Jaguar Health?
Jaguar Health has a free cash flow of -$29.01M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Jaguar Health have, and what sector and industry does it belong to?
Jaguar Health employs approximately 49 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of Jaguar Health's shares?
The free float of Jaguar Health is 12.45M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $13.96M
- EPS (TTM)
- -$16.10
- Free Float
- 12.45M
- Revenue (TTM)
- $10.48M
- EBITDA (TTM)
- -$27.50M
- Free Cashflow (TTM)
- -$29.01M
Pricing
- 52W span
- $0.78$424.80
Analyst Ratings
The price target is $6.00 and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. It operates through the Human Health and Animal Health segments. The Human Health segment is involved in manufacturing human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment includes commercializing prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.
- Employees
- 49
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- US47010C8055
- Primary Ticker
- JAGX
Knockouts
Finance data from FactSet